Page 75 - AN-2-1

Advanced Neurology Alpha-synuclein, depression and neurodegeneration

https://doi.org/10.1016/S2468-2667(21)00249-8 deposition in Parkinson disease and cognitive impairment:
A systematic review. Mov Disord, 30: 928–935.
3. Farina N, Ibnidris A, Alladi S, et al., 2020, A systematic
review and meta-analysis of dementia prevalence in seven https://doi.org/10.1002/mds.26191
developing countries: A STRiDE project. Glob Public Health, 14. Kotagal V, Spino C, Bohnen NI, et al., 2018, Serotonin, beta-
15: 1878–1893. amyloid, and cognition in Parkinson disease. Ann Neurol,
https://doi.org/10.1080/17441692.2020.1792527 83: 994–1002.
4. Singhal BS, Khadilkar SV, 2014, Neurology in the developing https://doi.org/10.1002/ana.25236
world. Handb Clin Neurol, 121: 1773–1782. 15. Twohig D, Nielsen HM, 2019, α-synuclein in the
https://doi.org/10.1016/b978-0-7020-4088-7.00114-0 pathophysiology of Alzheimer’s disease. Mol Neurodegener,
14: 23.
5. Borumandnia N, Majd HA, Doosti H, et al., 2022, The trend
analysis of neurological disorders as major causes of death https://doi.org/10.1186/s13024-019-0320-x
and disability according to human development, 1990-2019. 16. Roberts HL, Schneider BL, Brown DR, 2017, α-synuclein
Environ Sci Pollut Res Int, 29: 14348–14354. increases β-amyloid secretion by promoting β-/γ-secretase
https://doi.org/10.1007/s11356-021-16604-5 processing of APP. PLoS One, 12: e0171295.
6. van den Kieboom R, Snaphaan L, Mark R, et al., 2020, The https://doi.org/10.1371/journal.pone.0171925
trajectory of caregiver burden and risk factors in dementia 17. Cong S, Xiang C, Zhang S, et al., 2022, Prevalence and clinical
progression: A systematic review. J Alzheimers Dis, aspects of depression in Parkinson’s disease: A systematic
77: 1107–1115. review and meta-analysis of 129 studies. Neurosci Biobehav
https://doi.org/10.3233/JAD-200647 Rev, 141: 104749.
7. Boland DF, Stacy M, 2012, The economic and quality of https://doi.org/10.1016/j.neubiorev.2022.104749
life burden associated with Parkinson’s disease: A focus on 18. Broen MP, Narayen NE, Kuijf ML, et al., 2016, Prevalence of
symptoms. Am J Manag Care, 18: S168–S175. anxiety in Parkinson’s disease: Systematic review and meta-
8. Mattap SM, Mohan D, McGrattan AM, et al., 2022, The analysis. Mov Disord, 31: 1125–1133.
economic burden of dementia in low-and middle-income https://doi.org/10.1002/mds.26643
countries (LMICs): A systematic review. BMJ Glob Health,
7: e007409. 19. Leung DK, Chan WC, Spector A, et al., 2021, Prevalence of
depression, anxiety, and apathy symptoms across dementia
https://doi.org/10.1136/bmjgh-2021-007409 stages: A systematic review and meta-analysis. Int J Geriatr
9. Roheger M, Brenning J, Riemann S, et al., 2022, Progression Psychiatry, 36: 1330–1344.
of socio-cognitive impairment from healthy aging to https://doi.org/10.1002/gps.5556
Alzheimer’s dementia: A systematic review and meta-
analysis. Neurosci Biobehav Rev, 140: 104796. 20. Lee Y, Oh JS, Chung SJ, et al., 2018, The presence of
depression in de novo Parkinson’s disease reflects poor
https://doi.org/10.1016/j.neubiorev.2022.104796 motor compensation. PLoS One, 13: e0203303.
10. Martinez-Martin P, Chaudhuri KR, 2018, Comprehensive https://doi.org/10.1371/journal.pone.0203303
grading of Parkinson’s disease using motor and non-motor
assessments: Addressing a key unmet need. Expert Rev 21. Jones JD, Kurniadi NE, Kuhn TP, et al., 2019, Depressive
Neurother, 18: 41–50. symptoms precede cognitive impairment in de novo
Parkinson’s disease patients: Analysis of the PPMI cohort.
https://doi.org/10.1080/14737175.2018.1400383 Neuropsychology, 33: 1111–1120.
11. Saredakis D, Collins-Praino L, Gutteridge DS, et al., 2019, https://doi.org/10.1037/neu0000583
Conversion to MCI and dementia in Parkinson’s disease:
A systematic review and meta-analysis. Parkinsonism Relat 22. van der Velden RM, Broen MP, Kuijf ML, et al., 2018,
Disord, 65: 20–31. Frequency of mood and anxiety fluctuations in Parkinson’s
disease patients with motor fluctuations: A systematic
https://doi.org/10.1016/j.parkreldis.2019.04.020 review. Mov Disord, 33: 1521–1527.
12. Merello M, Sabe L, Teson A, et al., 1994, Extrapyramidalism https://doi.org/10.1002/mds.27465
in Alzheimer’s disease: Prevalence, psychiatric, and 23. Botto R, Callai N, Cermelli A, et al., 2022, Anxiety and
neuropsychological correlates. J Neurol Neurosurg Psychiatry, depression in Alzheimer’s disease: A systematic review of
57: 1503–1509.
pathogenetic mechanisms and relation to cognitive decline.
https://doi.org/10.1136/jnnp.57.12.1503 Neurol Sci, 43: 4107–4124.
13. Petrou M, Dwamena BA, Foerster BR, et al., 2015, Amyloid https://doi.org/10.1007/s10072-022-06068-x

Volume 2 Issue 1 (2023) 10 https://doi.org/10.36922/an.326